Cargando…
Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
SIMPLE SUMMARY: MET is a receptor tyrosine kinase encoded by the MET proto-oncogene that has a significant role in cancer cell progression. Several drugs targeting MET are under development for the treatment of different cancers, including non-small-cell lung cancer (NSCLC). However, until now, rela...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105764/ https://www.ncbi.nlm.nih.gov/pubmed/35565287 http://dx.doi.org/10.3390/cancers14092150 |